Article
Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Jan 2007
Tercyak Kenneth P, Peshkin Beth N, Brogan Barbara M, DeMarco Tiffani, Pennanen Marie F, Willey Shawna C, Magnant Colette M, Rogers Sarah, Isaacs Claudine, Schwartz Marc D
Abstract excerpt
PURPOSE: Recent studies indicate that high-risk breast cancer patients (ie, women who carry mutations in BRCA1/2 genes) who opt for contralateral prophylactic mastectomy (CPM) have a substantially reduced risk of developing contralateral breast cancer. However, the immediate and long-term impact of this decision on women's quality of life and psychosocial functioning is largely unknown. In this study, we compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.